NewGenIvf(NIVF.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
NewGenIvf
NIVF.US
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company’s fertility treatment solutions include in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also provides IVF treatment; surrogacy and ancillary caring services, including regular body check, as well as vitamins, supplements, and medicines to surrogate mothers; and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company offers its services through its clinics.
386.88 B
NIVF.USMarket value -Rank by Market Cap -/-

Financial Score

19/01/2026 Update
C
Health Care ServicesIndustry
Industry Ranking57/82
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE153.04%A
    • Profit Margin381.16%A
    • Gross Margin9.20%E
  • Growth ScoreC
    • Revenue YoY-19.43%E
    • Net Profit YoY21690.95%A
    • Total Assets YoY2314.56%A
    • Net Assets YoY506.20%A
  • Cash ScoreD
    • Cash Flow Margin26.24%C
    • OCF YoY-19.43%E
  • Operating ScoreD
    • Turnover0.25D
  • Debt ScoreA
    • Gearing Ratio19.18%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Pre-market hot trades in US stocks: NewGenIvf pre-market down 17.88%; Beneficient pre-market down 17.11%

    NewGenIvf pre-market down 17.88%; Beneficient pre-market down 17.11%; A SPAC III Acquisition pre-market up 215.17%; Enveric Biosciences pre-market up 77.53%; Biodexa Pharmaceuticals pre-market up 72.24%

    Tracking Unusual Activity·
    US
    NIVF
    +8.83%
    US
    BENF
    -3.69%
    Tracking Unusual Activity·
    US
    NIVF
    +8.83%
    US
    BENF
    -3.69%

    NewGenIvf Group Ltd. posts nine-month 2025 net income of USD 17.5 million, up over 40 times

    NewGenIvf Group Ltd. reported a net income of USD 17.5 million for the nine months ending September 30, 2025, marking a significant increase driven by a USD 23.4 million gain from acquisitions. Revenue was USD 3.3 million, with general and administrative expenses at USD 5.7 million. The net asset value per share was USD 66.75. This financial update was published by NewGenIvf via GlobeNewswire.

    Reuters·
    US
    NIVF
    +8.83%
    Reuters·
    US
    NIVF
    +8.83%

    Pre-market hot trades in US stocks: NewGenIvf pre-market down 7.28%, active capital flow, sector trends trigger volatility attention

    NewGenIvf pre-market down 7.28%; Taoping pre-market up 80.37%; Fitell pre-market up 28.33%; MongoDB pre-market up 23.97%

    Tracking Unusual Activity·
    US
    NIVF
    +8.83%
    Tracking Unusual Activity·
    US
    NIVF
    +8.83%

    NewGenIvf Group Announces One-for-Five Reverse Stock Split

    NewGenIvf Group Ltd. announced a one-for-five reverse stock split of its Class A Ordinary Shares, effective December 1, 2025. This will reduce outstanding shares from 6.6 million to 1.3 million. Shares will continue trading on Nasdaq under the symbol "NIVF" with a new CUSIP number, G0544E402. The announcement was made via EDGAR by the U.S. SEC.

    Reuters·
    US
    NIVF
    +8.83%
    Reuters·
    US
    NIVF
    +8.83%

    NewGenIvf Group Announces 1-for-5 Reverse Stock Split

    NewGenIvf Group Ltd. has announced a 1-for-5 reverse stock split, reducing its outstanding Class A Ordinary Shares from approximately 4.84 million to about 969,000. This action is intended to help the company comply with Nasdaq’s minimum bid price requirement. The reverse split is set to take effect on or around December 3, 2025, with trading on a post-split basis commencing on that date.

    Reuters·
    US
    NIVF
    +8.83%
    Reuters·
    US
    NIVF
    +8.83%
    Posts
    View More

    $NewGenIvf(NIVF.US)

    • 0
    © 2026 Longbridge｜Disclaimer